| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/11/2004 | WO2002058750A8 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/11/2004 | WO2002058749A8 Carrier with solid fibrinogen and solid thrombin |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049024 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040049022 Single or multiple target anti-sense oligonucleotides (STA or MTA oligos) of low or no adenosine content for respiratory disease-relevant genes; effective in the prophylaxis and treatment of respiratory diseases and conditions |
| 03/11/2004 | US20040049021 Compositions and mehtods for treatment of Hepatitis C virus-associated diseases |
| 03/11/2004 | US20040049018 For inhibiting HIV virus |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049015 Antibodies specific to human prostacyclin synthase |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040049009 Aligning the amino acid sequences of antagonists/agonists of CRFR which differ in their antagonistic/agonistic properties, identifying position wherein the amino acid sequences are different, replacing the different amino acids |
| 03/11/2004 | US20040048871 Use of high dose intravenous methotrexate, with leucovorin rescue, to treat early multiple sclerosis and other diseases of the central nervous system |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048826 Oligonucleotides containing 2'-0-modified purines |
| 03/11/2004 | US20040048825 Oligonucleotides, specifically hybridizable with nucleic acids encoding CREB; treatment of hyperproliferative disorder such as cancer and diseases caused by aberrant apoptosis. |
| 03/11/2004 | US20040048824 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 03/11/2004 | US20040048822 Nucleic acid immunization |
| 03/11/2004 | US20040048821 Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048817 Methods of immunotherapy and diagnosis |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048815 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/11/2004 | US20040048812 Health supplement |
| 03/11/2004 | US20040048803 Treatment of thrombosis by administering a CD154 inhibitor, especially a metalloproteinase inhibitor. |
| 03/11/2004 | US20040048802 Hepatitis C virus inhibitors |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048800 Use of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048794 Can also be used to inhibit metastasis of any tumor cells released in the subject's blood circulation during a surgical resection of a tumor |
| 03/11/2004 | US20040048793 Therapeutic peptide-based constructs |
| 03/11/2004 | US20040048792 Antimicrobial peptides and methods of use thereof |
| 03/11/2004 | US20040048791 Method for treating neoplastic cells using cycloprodigiosin or salt thereof |
| 03/11/2004 | US20040048789 Pharmaceutical compositions |
| 03/11/2004 | US20040048788 Sh2 domain binding inhibitors |
| 03/11/2004 | US20040048784 With a varient of a protein synthesis inactivating toxin; a viral protease cleavage site is interposed between the A and B chains; variant of the type II ribosome inactivating protein is activated by digestion of the viral protease |
| 03/11/2004 | US20040048783 Acidic insulin preparations having improved stability |
| 03/11/2004 | US20040048782 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 03/11/2004 | US20040048781 Introducing into phagocytic cells that are in contact with immune complexes an inhibitor of a kinase endogenous to said cells associated with an Fc receptor present at the membrane of said cells |
| 03/11/2004 | US20040048777 Compounds and compositions for delivering active agents |
| 03/11/2004 | US20040048379 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution |
| 03/11/2004 | US20040048377 Methods and compositions involved in groucho-mediated differentiation |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048341 Vascular endothelial growth factor (VEGF) molecule and process for producing same |
| 03/11/2004 | US20040048340 Apoptosis Inducing Molecule-1 (AIM-I) polypeptides useful in biological, diagnostic, clinical or therapeutic arts |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048327 Aza-peptide epoxides |
| 03/11/2004 | US20040048314 Novel physiologically active peptide and use thereof |
| 03/11/2004 | US20040048307 Cell growth differentiation factors; for detecting increased muscle mass in food animals; kits |
| 03/11/2004 | US20040048304 95 human secreted proteins |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048285 Nucleotide and amino acid sequences of several G protein coupled receptors |
| 03/11/2004 | US20040048284 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048273 Regulation of human secretin receptor-like gpcr |
| 03/11/2004 | US20040048271 Fibroblast growth factor 11 |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048249 Novel nucleic acids and secreted polypeptides |
| 03/11/2004 | US20040048248 Isolated polypeptide of given sequence; antibodies that bind immunospecificaly; treatment of diabetes, metabolic disorders, cancer, cachexia and dyslipidemia |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040048237 Mammalian prion proteins and transgenic mice expressing them |
| 03/11/2004 | US20040047922 Prevents the development of atherosclerosis |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047895 Laver protein-containing composition and foods |
| 03/11/2004 | US20040047890 Containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; treating subject with a substance which inhibits an immune-system costimulation |
| 03/11/2004 | US20040047883 For producing drug for stimulating the immune defences of the organism towards viral, parasitic or bacterial infections or cancerous antigens |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047876 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
| 03/11/2004 | US20040047873 Materials and methods relating to the increase in protein activity |
| 03/11/2004 | US20040047870 For therapy of atherosclerosis, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, stenosis, restenosis and/or in-stent-stenosis |
| 03/11/2004 | US20040047864 Apoptosis inducing molecule I |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047861 For therapy and prophylaxis of thrombosis, in particular in inflammatory diseases, rejection of a transplant, transplant mediated arteriosclerosis, high blood pressures in kidney diseases, vessel restenosis after bypass surgery, stent |
| 03/11/2004 | US20040047857 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 03/11/2004 | US20040047855 Methods for performing non-surgical lung volume reduction in a patient by (a) administering, through the patient's trachea, a composition comprising an enzyme (e.g., a protease, such as a serine protease (e.g., trypsin, chymotrypsin, elastase, or |
| 03/11/2004 | US20040047853 Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
| 03/11/2004 | US20040047852 Method of treating cancer |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047847 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047843 Method for spinal cord reconnection in a damaged spinal cord which includes disposing white matter stem cells or cells capable of developing characteristics of neuronal or supporting cells in an area of spinal cord damage in a |
| 03/11/2004 | US20040047838 Tissue flap angiogenesis |
| 03/11/2004 | US20040047837 An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein |
| 03/11/2004 | US20040047808 Method of treating cystic fibrosis in a human subject diagnosed with cystic fibrosis, comprising administering to the subject, in a pharmaceutically acceptable carrier, an effective amount of a fusion protein, comprising a cystic |
| 03/11/2004 | US20040047805 Therapeutic use of the SMR1 protein and active derivatives thereof |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | DE10240417A1 Decoy-Oligonukleotid-Hemmung der CD40-Expression Decoy Oligonucleotide inhibition of CD40 expression |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | DE10240118A1 Characterizing and identifying proteins specific for renal cell carcinoma, useful for diagnosis, prognosis, prevention and treatment, comprises comparing proteome patterns of healthy and diseased tissue |